FDA Investigator Richmond K Yip

Richmond K Yip has inspections in 6 countries as of 13 Oct 2023. Richmond K Yip has collaborated with a combinined 5026 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
85
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, France, Japan, India, Italy
Co-Investigator(s):
Alan L Truong, Alan P Kurtzberg, Alejandra Mcclellan, Alexander M Kay, Alexandra B Pitkin, Alexandria L Capuano, Amalia C Himaya, Amalia Himaya, Amanda L Fyles, Ana Djurdjevic, Anastasia M Shields, Angela Shepas, Angelina M Albert, Anita Narula, PhD, April P Shaw, Arie C Menachem, Armando Chavez, MS, Armando Forest, MS, Arsen Karapetyan, Babajide Michael Osunsanmi, Barbara J Rincon, Barry Cherney, PhD, Bichsa T Nguyen, Bichsa T Tran, Binh T Nguyen, Bo Chi, PhD, Bonnie I Needleman, Bowman, Brian D Nicholson, Brian E Thompson, Brian J Ryan, Brian P Putz, Brien C Fox, Bryan A Galvez, Bryan L Mcguckin, Bush, Caludia Mperez Kasmarski, Carla J Lundi, Carr Sharpe, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, Celena Ngo, Charles D Brown, Charles L Larson, Chelsea N Sealey, Cheron M Portee, Chong Ming Cheng, Chorng M Cheng, Christina D Mello, Christina V Santos, Christopher D Washington, Christopher J Freebairn, Christopher M Jenner, Christopher R Czajka, Claudia Mperez Kasmarski, Cynthia Jim, CSO, Daniel W Cline, Darren S Brown, Darrin E Davis, David G Whitman, David H Hsu, David Y Hernandez, Davinna Ligons, PhD, Davis, Deborah A Greco, Deborah G Park, Deborah W Hsu, Debra J Fracassa, Desiree C Iya, Devon Jenkins, Deyaa Shaheen, Diana M Rand, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Donna Ltartaglino Besone, Donna Mwilliams Hill, Dr. Chunchang Fang, Dyana K Stone, Eileen T Dupont, Elaine A Bunch, Esther B Gamallo Herrera, Evelyn Wong, Finn A Slizza, Frances Namuswe, PhD, Francisco, Gabriel Craig, Garciam, Gene D Arcy, George J Flynn, Gordon Chu, Greg K Keshishyan, Guerlain Ulysse, Guillermo, Hagstrom, Haley H Seymour, Haley Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Helen Verdel, Herminio C Francisco, Hinh T Nguyen, Hoover, Hung H Do, MS, Iris C Macinnes, Ivar J Sohn, Jai P Singh, James P Stallings, James R Fleckenstein, Jane S Wernberg, Jasmine N Thompson, Javier O Vega, Jee Chung, PhD, Jeff M Uriarte, Jeffery A Johnson, Jeffrey P Raimondi, Jennifer Gogley, Jennifer M Gogley, Jessica L Pressley, Jinnie Kokiatkulkij, Joanne E King, Joel D Hustedt, Joel Welch, PhD, Joey V Quitania, John A Gonzalez, John R Myung, Jolanna A Norton, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose R Hernandez, Joshua P Wireman, Juan J Casado, Juanita Banuelos, Judy C Nepsa, Julia Ventura, Jun Park, PhD, Ka L Wong, Kai Wang, Kari M Johansen, Katherine E Jacobitz, Katherine Szestypalow, Kathleen R Jones, PhD, Kelley, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kenneth Miller, Kenneth V Miller, Kevin D Kallander, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Kirsten S Tharp, Kirtida Patel, Kristy A Zielny, Lance A Finnical, Langer, Lata C Mathew, PhD, Laura Fontan, MS, Lee, Leonard H Lavi, Lilly O Barton, Lilly Olivia Barton, Liming Zhang, Linda F Murphy, Linda Thai, Lindsey M Schwierjohann, Loretta J Jordan, LT Tamara J Henderson, Lucila B Nwatu, Luis A Dasta, M Aabel I, M Jasnethoson Thompson, Mai X Huynh, Marcellinus D Dordunoo, Marcia Britt Williams, Marcus F Yambot, Marianela Aponte Cruz, Marie F Morin, Mark C Saale, Mary Ewilkerson Brinsko, Matt D Suedkamp, Matthew B Casale, Matthew R Clabeaux, Maurice M Sheehan, Maxyne T Lam, Michael D Garcia, Michael S Araneta, Michele L Obert, Michelle A Marsh, Michelle J Hines, Mihaly S Ligmond, Mohsen Rajabi Abhari, FDA, Muralidhara B Gavini, PhD, Nabeela J Chaudhry, Natalie J Ayoub, Nelly N Tran, Nianna C Burns, Nicholas L Hunt, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Omotunde O Osunsanmi, Patty P Kaewussdangkul, Peter S Diak, Phillip J Sample, Phillip L Toy, Rabin N Ghoshal, Rafael A Kaup, Randall N Johnson, Randy L Self, Raymond W Brullo, Rebecca Rodriguez, Regina T Brown, Richard A Abate, Richard W Tubb, Robert C Hoover, Robert D Tollefsen, Robert Darius, Robert T Lorenz, Rocio Guzman Velazquez, Roger F Zabinski, Ronald L Koller, Ronda Lebland, Rory K Geyer, Rumany C Penn, PharmD, S Lori Brown, PhD MPH, Saied A Asbagh, Sandersk, Sandra A Boyd, Sandra L Shire, DMD, MPA, Santiago Gallardo Johnson, Sarah A Hassas, Sarah Arden, Scott R Nichols, PhD, Sean P Desbrow, Selene T Torres, Sherri N Rohlf, MD, Shirley H Isbill, Sidney B Priesmeyer, Sidonie J Takougang, Simone E Pitts, Sonia R Peterson, Sonya L Karsik, Stacie A Woods, Stanley Au, State Agency, Stephanie A Slater, MS, Steven Fong, MS, PhD, Sue Lee Chan, Sumit Sen, Sundy Ven, Susan K Bain, Susan P Bruederle, Susan W Ting, Susanna N Choi, Taichun Qin, PhD, Tamala P Bogan, Tamala P Magee, Tamara L Ely, Tanya E Malais, Tara L Stockton, Tawny L Colling, Ted L Anderson, Terri L Dodds, Thanh M Andrews, Thao T Kwan, Thao Tran, Thao X Tran, That T Kwan, Thomas R Beilke, Timothy T Kapsala, Tony J Wu, Tracey T Duong, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vasant G Malshet, PhD, Vashti E Bocker, Victor H Loo, Vioela J Caze, Virgilio F Pacio, CSO, Walden H Lee, Wenzheng Zhang, Yi Lin, Yumi J Hiramine, Yvette E Guillermo, Yvette Mlacour Davis, Yvonne C Wilkes, Yvonne T Lacour, Zachary A Bogorad, Zachary L Miller

Richmond K Yip's Documents

Publish Date Document Type Title
March, 2001 FDA 483 Response Truett Laboratories, Inc. - Form 483R, 2001-06-04
December, 2000 FDA 483 Stephen G. Thein, Ph.D. - Form 483, 2000-12-22
July, 2002 EIR Amgen, Inc - EIR, 2002-07-25
July, 2000 EIR NBTY Acquisition LLC - EIR, 2000-07-13
July, 2019 EIR Johnson & Johnson Private Limited - EIR, 2019-07-10
July, 2010 FDA 483 Response PureTek Corporation - Form 483R, 2010-07-28
September, 2003 EIR Sumitomo Chemical Company, Limited - EIR, 2003-10-09
July, 2002 FDA 483 Response Amgen, Inc - Form 483R, 2002-08-09
July, 2010 FDA 483 Person and Covey - Form 483, 2010-07-23
September, 2003 FDA 483 Response Sumitomo Chemical Company, Limited - Form 483R, 2003-09-30
October, 2018 FDA 483 DISHMAN CARBOGEN AMCIS LIMITED - Form 483, 2018-10-26
June, 2002 FDA 483 Merck Lipha S.A.S. Centre de Production de Meyzieu - Form 483, 2002-06-11
May, 2000 EIR Ishaque, Saleem MD - EIR, 2000-05-10
November, 2018 FDA 483 Response INDUSTRIA FARMACEUTICA GALENICA SENESE SRL - Form 483R, 2018-12-07
July, 2002 FDA 483 Amgen, Inc - Form 483, 2002-07-25
August, 2003 FDA 483 Nisshin Pharma Inc. - Form 483, 2003-08-29
March, 2001 FDA 483 Truett Laboratories, Inc. - Form 483, 2001-03-16
September, 2001 FDA 483 Gary J. Schiller, MD - Form 483, 2001-09-21
August, 2003 FDA 483 Response Astellas Pharma Inc. - Form 483R, 2003-09-18
March, 2001 EIR Truett Laboratories, Inc. - EIR, 2001-03-16
February, 2003 EIR Watson Pharmaceuticals Inc - EIR, 2003-02-24
May, 2013 EIR Johnson & Johnson Consumer Inc. - EIR, 2013-05-16
December, 2002 FDA 483 PureTek Corporation - Form 483, 2002-12-12
September, 2003 FDA 483 Sumika Fine Chemicals Co. - Form 483, 2003-09-04
September, 2001 EIR Gary J. Schiller, MD - EIR, 2001-09-21
May, 2001 FDA 483 Response Sokol, William N., M.D. - Form 483R, 2001-05-18
October, 2001 EIR Chu, Franklin M., M.D. - EIR, 2001-10-11
November, 2001 FDA 483 B. Braun Medical Inc. - Form 483, 2001-11-20
March, 2002 FDA 483 Med-Pharmex, Inc - Form 483, 2002-03-20
October, 2001 FDA 483 Chu, Franklin M., M.D. - Form 483, 2001-10-11
May, 2001 EIR Sokol, William N., M.D. - EIR, 2001-05-09
October, 2018 EIR DISHMAN CARBOGEN AMCIS LIMITED - EIR, 2018-10-26
July, 2019 EIR Glenmark Life Sciences Limited - EIR, 2019-07-05
August, 2003 EIR Astellas Pharma Inc. - EIR, 2003-10-08
August, 2000 EIR NBTY Acquisition LLC - EIR, 2000-08-09
August, 2003 FDA 483 Response Shimadzu Techno Research Inc. - Form 483R, 2003-10-21
July, 2000 FDA 483 Gill, Parkash S., M.D. - Form 483, 2000-07-13
July, 2019 FDA 483 Glenmark Life Sciences Limited - Form 483, 2019-07-05
December, 2000 EIR Stephen G. Thein, Ph.D. - EIR, 2000-12-22
November, 2018 EIR INDUSTRIA FARMACEUTICA GALENICA SENESE SRL - EIR, 2018-11-16
February, 2002 FDA 483 NAMSA, LLC - Form 483, 2002-02-01
November, 2001 EIR B. Braun Medical Inc. - EIR, 2001-12-18
August, 2003 FDA 483 Astellas Pharma Inc. - Form 483, 2003-08-22
October, 2002 FDA 483 Maruchan, Inc. - Form 483, 2002-10-03
November, 2018 FDA 483 INDUSTRIA FARMACEUTICA GALENICA SENESE SRL - Form 483, 2018-11-16
March, 2020 EIR Johnson & Johnson Consumer Inc. - EIR, 2020-03-11
June, 2002 FDA 483 Merck Sante SAS - Form 483, 2002-06-18
January, 2000 EIR Joseph S. Gimbel, MD - EIR, 2000-01-28
July, 2000 FDA 483 Response NBTY Acquisition LLC - Form 483R, 2000-07-31
July, 2000 FDA 483 Leiner Health Products, Inc. - Form 483, 2000-07-13
July, 2000 EIR Gill, Parkash S. Md - EIR, 2000-07-13
July, 2010 FDA 483 PureTek Corporation - Form 483, 2010-07-16
August, 2003 EIR Shimadzu Techno Research Inc. - EIR, 2003-10-08
November, 2002 FDA 483 Truett Laboratories, Inc. - Form 483, 2002-11-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more